Cas 1242297-52-4,methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester

1242297-52-4

Post Buying Request

Basic information

Product Name: methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester
Synonyms: methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester
CAS NO:1242297-52-4
Molecular Formula:
Molecular Weight: 338.363
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester(1242297-52-4)
EPA Substance Registry System: methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester(1242297-52-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1242297-52-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1242297-52-4 Suppliers

Recommended suppliers

1242297-52-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1242297-52-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,2,2,9 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1242297-52:
(9*1)+(8*2)+(7*4)+(6*2)+(5*2)+(4*9)+(3*7)+(2*5)+(1*2)=144
144 % 10 = 4
So 1242297-52-4 is a valid CAS Registry Number.

1242297-52-4Upstream product

1242297-52-4Downstream Products

1242297-52-4Relevant academic research and scientific papers

SUBSTITUTED AZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES, AND METHOD FOR TREATING PARKINSON'S DISEASE USING THE SAME

-

Paragraph 798-801, (2010/09/17)

Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the derivative, and a method for treating Parkinson's disease in a mammal including administering an e

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1242297-52-4